Anat Cell Biol 2021; 54(4): 448-464
Published online December 31, 2021
Copyright © Korean Association of ANATOMISTS.
Medical Histology and Cell Biology Department, Faculty of Medicine, Mansoura University, El Mansoura, Egypt
Correspondence to:Hanaa Attia Khalaf
Medical Histology and Cell Biology Department, Faculty of Medicine, Mansoura University, El Mansoura 35516, Egypt
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Bleomycin (BLM) is one of anti-cancerous drugs. One of its limitation is the development of pulmonary fibrosis during therapy So, we proposed to examine the outcome of BLM take on the light and electron microscopic design of rat lung. Along with, assessment the probable protecting role of ginsenoside on BLM induced pulmonary changes. In this study, thirty adult male albino rats were comprised and were classified to four clusters; Negative & positive control group, BLM treated group and BLM& ginsenoside treated group. The lung was treated for histological and immunohistochemical (anti-p65) studies. Light microscopic examination of H&E stained sections of BLM treated group showed huge distortion of the lung building. Mallory trichrome stain of this group showed evident deposition of collagen fibers in the markedly thickened interalveolar septa and around intrapulmonary bronchi, bronchioles and blood vessels. Moreover, strong positive staining for nuclear factor (NF)-κB in the wall of bronchiole as well as the thickened interalveolar septa were observed. Ultrastructural inspection of lung of this group revealed muddled lung planning. Marked improvement of the lung structure and marked reduction in NF-κB immunoexpression was appeared in BLM and ginsenoside treated group. So, we concluded that co-administration of ginsenoside with BLM significantly enhanced the histological and morphometric image of the lung.
Keywords: Bleomycin, Ginsenosides, Pulmonary fibrosis, Nuclear factor-kappa B
Pulmonary fibrosis is considering a long-standing irrevocable advanced interstitial lung disease with poorly outcome leading to high rates of morbidity and mortality . It is considered to be the most important complication of chemotherapeutic agents .
It is accompanying with an average survival rate of not more than 3 years. This disease is characterized by damage of alveolar lining cells, epithelial-mesenchymal transition, activation and accumulation of fibroblasts as well as myofibroblasts leading to increased deposition of extracellular matrix (ECM) within the lung parenchyma . The disease is also associated with infiltration of the lung tissue by many inflammatory cells including neutrophils and eosinophils in association with increased synthesis of connective tissue and inhibition of proteases [4, 5]. These changes lead to complete destruction of the alveolar histoarchitecture ended by respiratory failure .
Bleomycin (BLM) is one of anti-cancerous drugs. It is recurrently used in treating various types of cancers like testicular, prostate, ovarian, breast and cervical tumor. One of the limitations of BLM usage is the development of pulmonary fibrosis during the course of therapy [7-9].
BLM causes oxidative stress, increases the production of pro-inflammatory cytokines and activation of fibroblasts causing complete alteration and damage of pulmonary structures that finally ended by pulmonary fibrosis .
Ginsenoside is the major bioactive component mined from the root of Panax ginseng, which is frequently used in treatment of respiratory, gastrointestinal and cardiovascular diseases . Pharmacological actions of ginsenoside have been confirmed in central nervous system and cancer counting anti-stress and anti-oxidant activities .
Ginsenoside has anti-fibrotic, anti-inflammatory, antioxidant [15, 16] and anti-tumor effects . Previous studies showed that ginsenoside has immunomodulatory effects that can be used for management of several immune system disorders and also attenuates lung inflammation and prevents the development of pulmonary fibrosis in rats [18, 19].
Many researches were established in the expectation of discovery a treatment that can deliberate disease evolution and hence advance survival of pulmonary fibrosis. However, pulmonary fibrosis remains a challenging disease to manage. As a result, there is an urgent need for new modulators of pulmonary fibrosis which interfere with the pathogenesis of the disease and prevent tissue remodeling [20, 21]. So, we proposed to examine the outcome of BLM take on the light and electron microscopic design of rat lung. Along with, assessment the probable protecting role of ginsenoside on BLM induced pulmonary changes.
BLM sulphat (bleocip): Bleomycin sulphate 15 mg ampoule (bleocip) was purchased from Cipla pharmaceutical company (Lower Parel, Mumbai, India).
Ginsenoside (ginseng): Ginsenoside 100 mg capsule (ginseng) was purchased from PHARCO pharmaceuticals Company (Alexandria, Egypt).
Nuclear factor-kappa B (NF-κB) (p65) rabbit Polyclonal Antibody Kits (catalog no. 14-6731): It was purchased from Thermo Fisher Scientific Co., Waltham, MA, USA.
All rats’ experimental protocols and procedures were performed authorizing to the international guidelines for the use of laboratory animals and acquired the Mansoura Faculty of Medicine Institutional Research Board (MFM-IRB) approval (with code number: MS/17.07.93). The duration of the experiment was 5 weeks. Thirty adult male albino rats (180–200 g) were involved in this study. Animals were put in plastic coops under hygiene conditions of aeration and temperature with ordinary laboratory nourish and water
Included 5 rats, received 0.5 ml of isotonic saline two times/week (by intraperitoneal injection) and normal saline (via orogastric tube) once daily, all for 4 weeks.
Included 5 rats received 0.5 ml of isotonic saline two times/week by intraperitoneal injection followed by 80 mg/kg ginsenoside dissolved in normal saline (via orogastric tube) once daily for 4 weeks [18, 22].
Included 10 rats received 0.5 mg of bleomycin sulphate (bleocip ampoule) dissolved in (0.5 ml) isotonic saline injected intraperitoneal (IP) two times/week for four weeks .
Included 10 rats received BLM injection like group III and ginsenoside (in a dose as group II) for one week before BLM injection and then concomitant with BLM injection (for 4 weeks).
On the day next the latest dosage, rats were deadened with intraperitoneal injection of sodium pentobarbital (40 mg/kg) . The animals were perfused via the left ventricle with 500 ml 10% neutral buffered formalin. The lung was quickly separated and processed for histological and immunohistochemical studies.
Left lung were excised and were put in 10% neutral buffered formalin (for fixation) and treated for light microscopic examination. Paraffin block obtained, sectioned (4–5 mm) and stained with hematoxylin and eosin (H&E) stain , Mallory’s trichrome stain .
Avidin-biotin complex technique was used . Samples were riding on positively charged slides, deparaffinization and rehydration were performed. Antigen retrieval for uncovering of antigens was performed by heating the sections in 10 mmol/L citrate buffer, (at pH 6) for two cycles. Hydrogen peroxide (3%) for 5 minutes were added to prevent the endogenous peroxide activity. The sections were incubated for 30 minutes with the primary monoclonal antibody, anti p65 (Thermo Fisher Scientific Co.) at dilution of 1:100 via phosphate buffered saline (PBS). Then, sections were bathed with PBS several times. Biotinylated goat linker was applied to the sections for 30 minutes (Thermo Scientific Co., Cheshire, UK), incubated with the avidin-biotin compound, then with peroxidase substrate solution for 5 minutes to mask the endogenous peroxide. Counterstain with Mayer’s hematoxylin was done. Negative control slides were put under the same circumstances after omitting the 1ry Ab with PBS . Spleen sections used to evaluate the positivity of the tissue sections.
Small fragments of right lungs were fixed in 2.5% buffered glutaraldehyde then post fixed with osmium tetroxide, dehydrated, cleared and then infiltrated in epoxy resin . Semi-thin sections (cut at 1 μm) were obtained and stained with toluidine blue. Ultrathin sections were sectioned and stained with uranyl acetate and lead citrate then examined using a JEOL transmission electron microscope (100 CX; Tokyo, Japan) at the Faculty of Science, Alexandria University, Alexandria, Egypt.
Slides were photo’d by Olympus® digital camera (E24-10 M pixel, China) connected to Olympus® microscope with 0.5 X photo adaptor. The outcome pictures were studied on Intel® Core I3® created computer via Video Test Morphology® software (Saint Petersburg, Russia) by a built-in routine for calibrated mechanized item study. We used it to measure width of the interalveolar septa (H&E stained sections), percentage area of collagenous fibers (Mallory trichrome stained section), percent area of NF-κB immunoreaction (NF-κB stained sections) and number of type II pneumocytes (semithin sections).
Lung samples were quickly isolated, perfused with PBS (pH 7.4) and with heparin to eradicate any red blood cells then centrifuge after instantly homogenized in potassium phosphate (pH 7.5). The supernatants were gotten and used for detection of superoxide dismutase (SOD) , catalase (CAT) , and level of malondialdehyde (MDA) .
The morphometric data and biochemical were evaluated via the computer program SPSS (statistical package for social science) version 20 (IBM Corp., Armonk, NY, USA). The meaning of difference was tested using ANOVA (Analysis of Variance) followed by post-hoc Tukey for many evaluations. Values are presented as mean±SD.
Light microscopic inspection of lung of control group sections stained with H&E displayed the standard systematized histological building of the lung. The alveoli were inflated (Fig. 1A). The bronchioles mucosa was creased and lined by columnar epithelium. Circular smooth muscle layer lied around the mucosa while adventitia was built of loose connective tissue (Fig. 1A). The intrapulmonary bronchi wall was designed of mucosa, musculosa and adventitia. The mucosa was lined by pseudostratified columnar ciliated epithelium with few goblet cells. The smooth muscle layer was spirally arranged around the mucosa. Adventitia, the outmost coat, exhibited plates of hyaline cartilage with normal chondrocytes some of them formed cell nest (Fig. 1B).
Light microscopic examination of H&E stained sections of BLM treated group revealed huge distortion of the lung building. Most of the alveoli appeared collapsed with few emphysematous ones. The interalveolar septa were markedly thickened with mononuclear cellular infiltration. Obviously dilated, congested and thickened blood vessels were observed (Fig. 1C). The wall of the bronchioles was markedly distorted with appearance of intraluminal cellular debris. The epithelium showed massive distortion with focal stratification. Smooth muscle layer was thickened and focally interrupted by massive peribronchiolar lymphocytic infiltration (Fig. 1C). The intrapulmonary bronchi showed massive distortion and thickening of its epithelial lining with focal stratification and intraluminal cellular fragments. Manifested mononuclear infiltration in the lamina propria and adventitia was seen. The cartilage plate in the adventitia showed degeneration of the chondrocytes with absent nuclei (Fig. 1D).
Light microscopic inspection of H&E stained sections of BLM and ginsenoside treated group exhibited planned lung architecture. Most of the alveoli appeared intact and inflated. The interalveolar septa appeared thin with focal thickenings and mononuclear cellular infiltration. The wall of blood vessels appeared normal (Fig. 1E). Intact epithelial lining of the bronchioles was observed with minimal peribronchiolar cellular infiltration and normal circular smooth muscle layer (Fig. 1E). The wall of the intrapulmonary bronchi appeared intact with normal epithelial lining. Slight mononuclear cellular infiltration was found in the lamina propria and the smooth muscle layer appeared thin. Intact hyaline cartilage plate in the adventitia appeared with normal chondrocytes (Fig. 1F).
Light microscopic inspection of Mallory’s trichrome stained sections of control groups showed fine collagen fibers in the interalveolar septa and around intrapulmonary bronchi, bronchioles and blood vessels (Fig. 2A, B). BLM treated group showed huge deposition of collagen fibers in the thickened interalveolar septa and around intrapulmonary bronchi, bronchioles and blood vessels (Fig. 2C, D). On the other hand, BLM and ginsenoside treated group showed mild collagen fibers deposition in the interalveolar septa and around intrapulmonary bronchi, bronchioles and blood vessels (Fig. 2E, F).
Light microscopic examination of anti-NF-κB stained sections of control groups showed negative immune-expression of NF-κB in the bronchiole and minimal expression in the interalveolar septa (Fig. 3A). BLM treated group showed strong positive staining for NF-κB in the mucosa and adventitia of bronchiole as well as the thickened interalveolar septa (Fig. 3B, C). However, BLM and ginsenoside treated group revealed mild NF-κB immue-expression in the mucosa and adventitia of bronchiole as well as the interalveolar septa (Fig. 3C).
Examination of semithin sections of lung of control rats showed inflated alveoli separated by interalveolar septa. These alveoli were lined by type I and type II pneumocytes. Few alveolar macrophages were seen. Blood capillaries lined by endothelial cells were also seen (Fig. 4A). Semithin sections of the lung of BLM treated group rats showed markedly distorted lung field with collapsed alveoli and thick interalveolar septa. The blood capillaries appeared congested. There was extensive infiltration by inflammatory cells including alveolar macrophages, lymphocytes and neutrophils. Numerous type II pneumocytes were detected (Fig. 4B). Semithin sections of the lung of BLM and ginsenoside treated group showed inflated alveoli with slightly thickened interalveolar septa. The blood capillaries were mildly congested. Mild increase of type II pneumocytes and some macrophages were observed (Fig. 4C).
Examination of ultrathin sections of studied groups; showed systematized lung field of the control group. Inflated alveoli were lined by type I and type II pneumocytes. They were disconnected by interalveolar septa (with its thin and thick parts) with minimal collagen fiber deposition. The capillaries lined by endothelial cells and contained RBCs (Fig. 5A, B). On the other hand, ultrastructural inspection of BLM treated group revealed muddled lung planning. Most of the alveoli were collapsed with the appearance of cellular debris. The interalveolar septa were markedly thickened with intensive collagen fiber deposition. The blood capillaries were obviously congested with distorted endothelium (Fig. 5C, D). Ultrastructural inspection of lung of BLM and ginsenoside treated group showed noticeable improvement in the lung building. Majority of the alveoli are inflated. The interalveolar septa are thin with mild collagen fiber deposition and containing mildly congested blood capillaries (Fig. 5E, F).
Electron microscopic picture of type I pneumocytes of control groups seemed flat and had large oval nuclei. The cytoplasm was contained few organelles as few mitochondria and few cisternae of rough endoplasmic reticulum (rER) (Fig. 6A). Type II pneumocytes of this group appeared cuboidal in shape, bulging into the alveolar lumen with short microvilli covering the cell surface. It had large rounded euchromatic nucleus with prominent nucleoli. Its cytoplasm contained mitochondria, cisternae of rER, saccules of Golgi apparatus and lamellar bodies with the characteristic closely packed concentric lamellae (Fig. 6B). Whereas, type I pneumocytes of BLM treated group were distorted with irregular heterochromatic nuclei. The cytoplasm showed shrunken mitochondria and dilated cisternae of rER with the presence of small vacuolations. Its basement membrane was markedly thickened by the extensive deposition of collagen fibers (Fig. 6C). Type II pneumocytes of this group were damaged with small irregular and heterochromatic nuclei. The cytoplasm showed electron dense mitochondria with disrupted cristae. The lamellar bodies showed degenerative changes leaving irregular empty vacuoles with loss of the concentric lamellae. The short microvilli covering the cell surfaces were damaged (Fig. 6D). On the other hand, type I pneumocytes seemed intact with euchromatic nuclei and intact organelles (Fig. 6E). Type II pneumocytes appeared slightly intact with large euchromatic nucleus and numerous short microvilli covering the cell surface. Their cytoplasm showed intact organelles and lamellar bodies with the appearance of the characteristic concentric lamellae (Fig. 6F).
The thickness of the interalveolar septa of BLM treated group showed highly significant increase when matched with that of control group (
The percentage area of the collagen fibers of BLM treated group showed highly significant increase when matched with that of control group (
The percentage area of positive NF-κB immune reaction of BLM treated group showed highly significant increase when matched with that of control group (
The mean number of types II pneumocytes of BLM treated group showed highly significant increase when matched with that of control group (
A highly significant increase in the MDA (
BLM is a commonly used chemotherapeutic agent. It is either used as a single agent or in combinations with other chemotherapeutic agents. BLM causes massive lung injury and fibrosis. The animal model of lung fibrosis induced by BLM resembles what occurs in human, so it is used in studying the mechanisms which cause rapid progression of the disease [33-35].
Ginseng has anti-inflammatory and antioxidant actions. It protects against lung injury and fibrosis so improves lung functions . Consequently, the existing work tried to assess the probable protective role of ginsenosides in BLM induced lung fibrosis.
In the current study, four weeks of BLM administration resulted in massive pulmonary changes. Majority of lung alveoli were collapsed with some emphysematous ones. The interalveolar septa were markedly thickened with evident mononuclear cellular infiltrations. Such findings coincide with those observed by Altintas et al.  and Tian et al. . The thickening of interalveolar septa was statistically confirmed and coincides with that found by Tang et al. .
This noticeable thickening may be due to increased deposition of collagen ﬁbers which is confirmed by Mallory trichrome stained sections and statistically by the high significant rise in the percentage area of collagen fiber matched with that of control rats. Moreover, this thickening may be the cause of collapsed alveoli. Additionally, collapsed alveoli may be also due to vascular congestion and depletion of the pulmonary surfactant [40, 41]. However, the presence of dilated alveoli could be result of epithelial, endothelial and basement membrane damage [42, 43].
The intrapulmonary bronchi and bronchioles of BLM administrated group showed marked distortion in their walls with thickening of their smooth muscle layer and extensive mononuclear cellular infiltration with degeneration of the chondrocytes of the hyaline cartilage plate. These changes are consistent with that of [44, 45].
Liu et al.  reported that the production of inflammatory agents as transforming growth factor beta (TGF-β) and tumor necrotic factor alpha (TNF-α) has a vital role in the proliferation and thickening of smooth muscle layer. Zaafan et al.  stated that BLM initiates oxidative stress with consequent increased production of reactive oxygen and nitrogen species. These oxidants stimulate many genes associated with cell growth and cell death. BLM also increases the production of pro-inflammatory agents as interleukin (IL)-6 and proteolytic enzymes leading to lipid peroxidation of the cell and defect in synthesis and degradation of lung prostaglandins [37, 48].
The degenerative changes of hyaline cartilage caused by BLM were mainly due to oxidative stress that lead to increase of COX-2 and prostaglandin E2 in chondrocytes causing its damage . As well as, some cytokines as TNF-α, IL1 act by promoting inflammatory responses and encouraging cartilage damage .
Thickening of the blood vessels wall and extravasation of RBCs may be due to deviations in the vascular integrity of the lung capillary leading to damage of the endothelial barrier and impairment in capillary permeability [23, 51, 52].
It is believed that BLM causes injury to the alveolar epithelium and its basement membrane; which is an essential step in the etiology of lung fibrosis. This injury leads to fibroblasts proliferation, marked increase in collagen deposition and accumulation of ECM proteins. As a result, interstitial edema, hemorrhage and thickened interstitium of the alveoli occur resulting in breakdown of connective tissue giving the picture of emphysema [48, 55, 56]. Moreover, many inflammatory cells migrate to and proliferate in sites of damage. These cells produce many cytokines causing more cell staffing and remodeling of matrix leading to excessive production of collagen and matrix components [57, 58]. Also, several inflammatory cytokines; especially TGF-β; are produced from the destructed lung tissue mainly through the activation of NF-кB pathway leading to production of fibroblasts [47, 48].
TGF-β can be secreted in the lung via many cells (macrophages, alveolar epithelial cells, endothelial cells, fibroblasts, as well as myofibroblasts). When activated, TGF-β leading to recruitment and proliferation of both macrophage and fibroblast [59, 60], causing more collagen deposition [55, 61].
Four weeks of BLM administration give rise to over expression of NF-кB in the lung tissue of the current work. This was confirmed by the high significant rise in the percentage area of positive immune reaction in the lung of BLM treated group matched with control groups. Similar results were obtained by Kabel et al. .
NF-κB is a member of dimeric DNA binding transcription agents. It modifies the vital responses to cellular stress via the regulation of effector genes expression . It is present in the cytoplasm of every cell and when activated translocate to the nucleus. Its activation is induced by free radicalsand toxins. Once it is activated, it regulates the expression of genes of several inflammatory agents as enzymes (COX-2 and iNOS) and many mediators (IL-1B, IL-6, TNF-α, and TGF-β), which are extremely related with the development of pulmonary fibrosis, especially TGF-β [64-66].
Toll like receptor 4 (TLR-4) is a crucial manager of the pro-inflammatory transcript NF-κB factor. Stimulation of TLR-4 signaling in fibroblasts give rise to increased collagen deposition and enhanced expression of several genes tangled in tissue repair and ECM .
NF-кB changes cell behavior in many ways; it regulates the transcription of large number of genes, especially those involved in immune and inflammatory responses and thus has a role in regulating inflammation, cell proliferation and apoptosis [64, 67]. Also, it acts as a significant controller of many functions including cellular proliferation; especially fibroblast; inflammation and differentiation [68, 69].
Many evidences showed that NF-κB signaling pathway can be activated by BLM and plays an important role in controlling inflammation [39, 38]. As well as it has an important role in BLM-induced pulmonary fibrosis [68, 69].
In the current work, semi thin sections of BLM treated group revealed marked rise in the quantity of types II pneumocytes and it was confirmed statistically. This could be attributed to destruction of type I pneumocytes with its replacement by the proliferating type II pneumocytes as the majority of the alveolar lining, type I pneumocytes, are more susceptible to injury induced by BLM . Cellular infiltration with inflammatory cells was also recorded. It was reported that many inflammatory cells are involved in different stages of lung fibrosis .
Macrophages are the chief cells elaborated in BLM administration. They produce IL-7 which has principle action in pulmonary fibrosis . Also, it has essential role in all phases of fibrosis via its extraordinary flexibility for adaptation to definite stimuli [57, 72].
In the present research, ultrastructural inspection of lung sections of BLM treated group revealed markedly thickened interalveolar septa with extensive deposition of collagen fibers and inflammatory cells infiltration. The alveoli were collapsed with the appearance of intra luminal cellular debris. Similar change was obtained by Kandhare et al. , Zhao et al. , and Zhou et al. .
Structural changes in both pneumocyte types were noted in the form of irregular nucleus, degenerated organelles, and cytoplasmic vacuolation in addition to degenerated lamellar bodies with loss of its concentric lamellae leaving irregular empty vacuoles. Similar observations were also recorded by others [23, 73].
Degenerative changes of organelles are explained by Hüttemann et al. , Liu and Chen  and Burman et al.  as adaptive processes to unfavorable conditions as excessive exposure to free radicals and hypoxia. The stressed mitochondria release cytochrome C which in turn activates caspase-9 initiating irreversible phases of apoptosis. This causes an increase in the lipid peroxidation and activation of the intrinsic pathway of apoptosis.
The cytoplasmic vacuolations might be due to the release of free radicals which alter Na/K pump role causing accumulation of sodium and migration of water to the cell. Moreover, any toxic agents may be aggregated in the form of vacuoles in the cell .
Changes of type II pneumocytes were linked with reduced production and release of lung surfactant as well as change in its composition and function. This defect could be attributed to ROS. The change in surfactant alters the pulmonary surface tension and lead to collapsed alveoli [23, 74].
The current work showed highly significant changes in the oxidative marker in lung tissue of BLM treated group; there was significant rise in level of MDA equivalent with a significant reduction of SOD and CAT levels matched with that of control groups. These data theorized the existence of oxidative stress in BLM treated group and it come in agreement with preceding studies [38, 80, 81].
In the existing work, lung sections of BLM and ginseng treated group showed marked improvement in lung structure more or less similar to that of control groups. The interalveolar septa were intact and thin with normal and inflated alveoli. Statistically there was high significant reduction in the thickness of the interalveolar septa of this group matched with that of BLM treated group. The epithelium of the intrapulmonary bronchi and bronchioles appeared intact with thin smooth muscle layer and minimal mononuclear cellular infiltration in the adventitia. The hyaline cartilage plate in the adventitia appeared intact with normal chondrocytes Similar results were obtained by Guan et al.  and Gao et al. .
In BLM and ginseng treated group, Mallory’s trichrome stained sections revealed minimal collagen fibers deposition in the interalveolar septa and around intrapulmonary bronchi, bronchioles and blood vessels. Statistically highly significant reduction in the percentage area of collagen fibers matched with that of BLM treated group. Similar results were run with that published by Zhou et al. .
Mild positive immune expression for NF-κB in BLM and ginseng treated group was detected and exhibited a high significant reduction matched with BLM treated group. These data come in line with Shergis et al. , Saba et al.  and Ahn et al. .
Improvement of lung field with few inflammatory cells and less frequent type II pneumocytes was detected in semithin sections of the lung of BLM and ginseng treated group. This was confirmed by high significant reduction in the mean number of types II pneumocytes in BLM and ginseng treated group when compared with that of BLM treated group rats. This reduction may be caused by the protective effect of ginseng which prevents the damage of type I pneumocytes and preserves their structure and number and thus prevents proliferation of type II pneumocytes.
Remarkably improvement of the lung building of BLM and ginseng treated group was also detected by electron microscopy. The lung design was conserved; the alveoli were inflated with thin interalveolar septa. Similar results were reported by Bilgin et al. . Type I and type II pneumocytes appeared intact. Type II pneumocytes showed intact lamellar bodies with their concentric lamellae. the cytoplasm showed intact organelles. Similar findings were reported by Ren et al. .
Ginseng has many pharmacologically bioactive ingredients including ginsenosides, polysaccharides, polyacetylenes, phytosterols, and essential oils. Ginsenosides are the chief active ingredients . Ginsenosides have powerful antioxidant and anti-inflammatory properties via scavenging free radicals and upregulation of antioxidant enzymes. Ginseng regulates inflammation through inhibition of lung pathological changes including edema, cellular infiltration and the release of inflammatory agents (TNF-α, TGF-β, IL-1β, IL-4, and IL-6) [36, 88].
Many studies have shown that ginseng inhibits lipid peroxidation and NF-κB activation. The pathogenesis of fibrosis mediated by many inflammatory agents (mainly TGF-β) which can be inhibited by ginseng .
It was also reported that ginseng inhibit lipid peroxidation, ameliorate the endothelial NO thus enhance endothelial dysfunction .
Ginsenosides inhibit NF-κB activation and thus prevent IL-1β-produced chondrocytes apoptosis and inflammation. The pro-inflammatory cytokine IL-1β has been proved to reduce chondrocytes viability, up-regulation of pro-apoptotic proteins and activates NF-κB signaling pathway . Moreover, previous reports have indicated that ginsenosides inhibit TNF-α-induced NF-κB activation .
The current work showed highly significant reduction in lung level of MDA equivalent with a significant rise of SOD and CAT levels in BLM and ginseng treated group matched with that of BLM treated group. These data consistent with Duguran et al.  who studied the antioxidant defensive potential of ginseng. It was manifested by a decrease in ROS which is the major contributor to oxidative stress which causes tissue damage by lipid peroxidation. This increase in lipid peroxidation was normalized or decreased by the intake of ginseng.
So, we can concluded that, ginsenosides expressively ameliorated BLM-induced pulmonary fibrosis through the inhibition of NF-κB activation in addition to their antifibrotic, antioxidant and anti-inflammatory activities. So, ginseng may be a meaningful adjuvant treatment with BLM to eliminate the hazardous of pulmonary fibrosis. Further studies are required to declare the possible mechanisms by which ginseng could mitigate BLM induced pulmonary fibrosis.
Conceptualization: DREB. Data acquisition: RAAAS. Data analysis or interpretation: NMO, HAK. Drafting of the manuscript: DREB, NMO, HAK. Critical revision of the manuscript: DREB, NMO, HAK. Approval of the final version of the manuscript: all authors.
No potential conflict of interest relevant to this article was reported.